Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Valeant Pharmaceuticals International Inc Completes Acquisition Of Bausch + Lomb Holdings Incorporated


Tuesday, 6 Aug 2013 07:01am EDT 

Valeant Pharmaceuticals International Inc announced that it has completed the previously announced acquisition of Bausch + Lomb Holdings Incorporated. Bausch + Lomb is a global eye health company that has a broad portfolio of eye health products, including well-known prescription and OTC brands Besivance, Lotemax, Ocuvite and PreserVision; vision care brands Biotrue ONEday, PureVision, renu and Boston; and surgical brands enVista, Storz, Stellaris and VICTUS. 

Company Quote

205.32
-2.04 -0.98%
17 Apr 2015